(Q43774292)

26 November 2017

0 references

Methylenedioxymethamphetamine (MDMA; 'Ecstasy') suppresses antigen specific IgG2a and IFN-gamma production (English)

1 reference

26 November 2017

T J Connor

1 reference

26 November 2017

D B Connelly

series ordinal

1 reference

26 November 2017

J P Kelly

series ordinal

1 reference

26 November 2017

publication date

1 September 2001

1 reference

26 November 2017

1 reference

26 November 2017

1 reference

26 November 2017

1 reference

26 November 2017

page(s)

67-73

1 reference

3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900231-0

7 January 2021

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900231-0

7 January 2021

Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900231-0

7 January 2021

Acute 3,4-methylenedioxymethamphetamine(MDMA) administration produces a rapid and sustained suppression of immune function in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900231-0

7 January 2021

An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900231-0

7 January 2021

Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses IL-1beta and TNF-alpha secretion following an in vivo lipopolysaccharide challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900231-0

7 January 2021

Brain corticotropin-releasing hormone- and interleukin-1 beta-induced suppression of specific antibody production

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900231-0

7 January 2021

Exercise and neuroendocrine regulation of antibody production: protective effect of physical activity on stress-induced suppression of the specific antibody response

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900231-0

7 January 2021

Mechanism and regulation of immunoglobulin isotype switching.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900231-0

7 January 2021

Suppression of polyclonal and antigen-specific murine IgG1 but not IgE responses by neutralizing interleukin-6 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900231-0

7 January 2021

Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900231-0

7 January 2021

Inhibition of gamma interferon synthesis by catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900231-0

7 January 2021

Virally induced modulation of murine IgG antibody subclasses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900231-0

7 January 2021

IgG2a restriction of murine antibodies elicited by viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900231-0

7 January 2021

Effects of amphetamine on T-cell immune response in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900231-0

7 January 2021

Effects of amphetamine on influenza virus infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900231-0

7 January 2021

10.1016/S0165-2478(01)00231-0

Identifiers

DOI

1 reference

26 November 2017

1 reference